SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as it officially joins the Russell 2000 and 3000 indexes, sparking heavy debate between bulls focused on institutional inflows and bears highlighting concerns over share dilution and price volatility. Community sentiment remains polarized, with many traders closely monitoring short interest and index-related buying pressure while others debate if recent price weakness marks a buying opportunity or a deeper correction.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is experiencing significant upward momentum and heightened community excitement driven by anticipation for the REGAL trial's final data readout and persistent buyout rumors. Investors are actively discussing the potential for a massive short squeeze due to high short interest and limited share availability, as they look toward a long-term re-rating of the stock.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is seeing heightened investor attention driven by a combination of a significant earnings beat and a massive surge in defense-related drone demand, with the community actively debating whether the stock is primed for a major squeeze or facing headwinds from softer forward guidance. Investors are closely tracking the company's large backlog and its role in the shifting landscape of military autonomy, while analyzing potential technical setups that could signal a sustained reversal.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy Enterprises is trending as investors focus on its long-duration zinc-based energy storage solutions, which are increasingly viewed as a critical fix for AI data center energy bottlenecks. Market conversation is currently dominated by a mix of positive sentiment regarding recent operational milestones, such as its new manufacturing line, and ongoing debate over potential share dilution and short interest levels.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending as investors debate whether the recent decline to multi-year lows represents an overblown reaction to ad-tech competition or a structural shift, with community sentiment split between frustration over management's lack of communication and conviction that the stock is deeply undervalued. Much of the discourse centers on clearing the overhang from the Publicis dispute, the potential for an ad-spend rebound, and speculation regarding new partnerships as the company maintains a strong balance sheet amidst volatile sector-wide software sell-offs.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is rallying as traders closely track the firm's pivot toward solid-state transformer (SST) technology for the AI data center market. The community is actively debating the stock's potential for a massive short squeeze and long-term mean reversion, with many focused on institutional accumulation and insider buying as indicators of future growth.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is experiencing intense volatility as investors react to Phase 3 trial data that showed best-in-class efficacy for obefazimod while simultaneously sparking concerns over potential malignancy signals in the higher-dose arm. Community discussion is heavily divided between retail investors viewing the sell-off as a manipulative overreaction to noise and institutional analysts who are downgrading the stock, citing increased regulatory risks and a more complex path to approval or acquisition.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is seeing significant market enthusiasm as the company secures multiple high-value contracts for its small modular reactors and wide-body aircraft engines. Community sentiment remains largely bullish, with investors focusing on the firm's strategic expansion in defense and nuclear energy as key catalysts for long-term growth.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack In The Box is trending as investors react to the company's decision to divest its Del Taco subsidiary for a significant loss, a move aimed at deleveraging its balance sheet and refocusing on its core brand. Community discussion is heavily divided between those viewing the sale as a necessary step toward operational efficiency and those concerned about the company's long-term debt levels and the steep financial loss incurred on the deal.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is rallying sharply as market enthusiasm builds around reports that the company and its partner, Rakuten, have been selected for Japan's billion-dollar J-LEO sovereign satellite contract. Investors are actively discussing this deal as a major competitive win over SpaceX, fueling a short squeeze as the community anticipates further official announcements and expansion of the company's global direct-to-device network.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why Humacyte, Inc. (HUMA) Fell More Than Broader Market

Humacyte, Inc. (HUMA) concluded the recent trading session at $0.62, signifying a -11.14% move from its prior day's close.

Brokers Suggest Investing in Humacyte, Inc. (HUMA): Read This Before Placing a Bet

The average brokerage recommendation (ABR) for Humacyte, Inc. (HUMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Humacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should Know

Humacyte, Inc. (HUMA) closed the most recent trading day at $1.03, moving 3.74% from the previous trading session.

Humacyte, Inc. (HUMA) Upgraded to Buy: Here's What You Should Know

Humacyte, Inc. (HUMA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

HUMA Stock Plunges After-Hours On Proposed Share Offering Even As Dialysis Data Impresses

Equity

The size and price of the stock offering were not disclosed.


Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, June 5, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We...

Wall Street Bulls Look Optimistic About Humacyte, Inc. (HUMA): Should You Buy?

According to the average brokerage recommendation (ABR), one should invest in Humacyte, Inc. (HUMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Are Medical Stocks Lagging  Agilon Health (AGL) This Year?

Here is how Agilon Health (AGL) and Humacyte, Inc. (HUMA) have performed compared to their sector so far this year.

Why Humacyte, Inc. (HUMA) Price Target Was Raised Despite Early-Stage Commercialization

Why Humacyte, Inc. (HUMA) Price Target Was Raised Despite Early-Stage Commercialization...

Humacyte Reports Q1 2026 Results: Full Earnings Call Transcript

Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.

Humacyte Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.10	--	--	N/A
Q1 '26	-$0.12	-$0.09	22.20%	BEAT
Q4 '25	-$0.13	-$0.13	3.60%	BEAT
Q3 '25	-$0.15	-$0.11	27.17%	BEAT
Q2 '25	-$0.16	-$0.24	-48.35%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

HUMAHumacyte Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest HUMA News